London, UK, 09 August 2018 - Instinctif Partners, the international business communications consultancy, congratulates the nominees shortlisted as finalists for the 2018 OBN Awards. Now in its 10th anniversary, the OBN Awards are one of the most prestigious and competitive awards events in the UK life sciences industry, this year receiving a 40% increase in award entries compared to 2017.
Particular congratulations go to the four clients of Instinctif Partners Life Sciences’ practice who have reached the finalist stage: Healx (for Best Emerging Biotech Company), Astex Pharmaceuticals and F-Star (both for Best Established Biotech Company), and DNA Electronics (for Best Diagnostic Medtech Company).
The full list of award categories and finalists, as well as further information on the awards can be found here: https://www.obn-awards.com/. The winners will be announced at the OBN Awards evening on Thursday 11 October at the Examination Schools in Oxford.
Commenting on the announcement of the shortlisted nominees, Sue Charles,
Managing Partner of Instinctif Partners Life Sciences’ practice, BIA Board Member and member of the voting OBN Awards panel said:
“Awards are a great opportunity to highlight the progress made in the UK life sciences industry over the past year, and to celebrate the achievements of those who have been at the forefront of the impressive advancements being made. The OBN Awards go from strength to strength and we’d like to recognise all of those that entered and congratulate the shortlisted companies.”
About Instinctif Partners Life Sciences
Instinctif Partners is a leading international business communications consultancy and has recently been awarded International Agency of the Year at the PR Week Global Awards 2017. The firm has an exceptionally strong dedicated team focused in the Life Sciences sector. This Life Sciences practice has expertise across financial, corporate, healthcare and marketing communications, and integrates design and digital into its communications mix. Offering global outreach, its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.